TLP
ABBV icon

Trinity Legacy Partners’s AbbVie ABBV Stock Holding History

Trinity Legacy Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,224
Closed -$218K – 95
2024
Q4 		$218K Hold
1,224
– – 0.06% 89
2024
Q3 		$239K Hold
1,224
– – 0.06% 91
2024
Q2 		$210K Hold
1,224
– – 0.06% 97
2024
Q1 		$223K Sell
1,224
-935
-43% -$161K 0.07% 98
2023
Q4 		$335K Sell
2,159
-35
-2% -$5.1K 0.11% 85
2023
Q3 		$327K Sell
2,194
-27,123
-93% -$3.98M 0.11% 81
2023
Q2 		$3.95M Buy
29,317
+283
+1% +$41.5K 1.38% 32
2023
Q1 		$4.63M Buy
29,034
+980
+3% +$150K 1.74% 22
2022
Q4 		$4.53M Sell
28,054
-2
-0% -$307 1.81% 24
2022
Q3 		$3.77M Sell
28,056
-2,262
-7% -$325K 1.61% 25
2022
Q2 		$4.65M Sell
30,318
-3,265
-10% -$499K 1.81% 20
2022
Q1 		$5.44M Buy
33,583
+783
+2% +$114K 1.84% 19
2021
Q4 		$4.44M Buy
32,800
+1,606
+5% +$190K 1.51% 22
2021
Q3 		$3.37M Buy
31,194
+1,502
+5% +$172K 1.21% 30
2021
Q2 		$3.5M Buy
29,692
+2,485
+9% +$280K 1.29% 27
2021
Q1 		$2.94M Buy
27,207
+6,510
+31% +$696K 1.17% 30
2020
Q4 		$2.22M Sell
20,697
-2,002
-9% -$192K 1.01% 32
2020
Q3 		$1.99M Buy
22,699
+660
+3% +$62.1K 0.96% 28
2020
Q2 		$2.18M Buy
22,039
+12,487
+131% +$1.1M 1.12% 27
2020
Q1 		$718K Buy
9,552
+1,262
+15% +$107K 0.51% 38
2019
Q4 		$748K Buy
8,290
+5,155
+164% +$428K 0.35% 43
2019
Q3 		$231K Buy
+3,135
New +$215K 0.11% 57

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Trinity Legacy Partners's ABBV Position: Q1 2025 in Review

Trinity Legacy Partners sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 1,224 shares — an estimated $218K sold.

Trinity Legacy Partners first reported a position in ABBV in Q3 2019 and held it in 22 quarters. The position peaked at $5.44M in Q1 2022. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Trinity Legacy Partners reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Trinity Legacy Partners sold 1,224 AbbVie shares in Q1 2025, an estimated $218K.
  • Trinity Legacy Partners first reported a position in AbbVie in Q3 2019 and held it in 22 quarters.
  • Trinity Legacy Partners's AbbVie position peaked at $5.44M in Q1 2022.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Trinity Legacy Partners's 13F filing for Q1 2025, filed 14 May 2025.